NCT06540547 Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study
| NCT ID | NCT06540547 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | ADHD |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-01-19 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2025-01-19 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will develop and test a behavioral program for pregnant individuals with Attention-Deficit/Hyperactivity Disorder (ADHD). This behavioral program will include skills for managing ADHD and related symptoms during pregnancy and after delivery and will be taught by a behavioral therapist in OB care settings.
Eligibility Criteria
Inclusion Criteria: * (1) meet full DSM-5 criteria for ADHD * (2) are between 20- and 32-weeks of gestation * (3) speak English * (4) will deliver at the University of Pittsburgh Medical Center (UPMC) Magee Women's Hospital (MWH) Exclusion Criteria: * (1) active substance use disorder * (2) intellectual disability * (3) other severe mental illness, including bipolar disorder, psychosis, and major depressive disorder with suicidal ideation or requiring higher level of care (inpatient or partial/intensive outpatient) * (4) high risk pregnancies requiring transfer of care to Maternal-Fetal Medicine (e.g., maternal cancer, multiples, placenta accreta) and/or fetus known to have a severe congenital condition.
Contact & Investigator
Heather M Joseph, DO
PRINCIPAL INVESTIGATOR
University of Pittsburgh
Frequently Asked Questions
Who can join the NCT06540547 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 55 Years, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06540547 currently recruiting?
Yes, NCT06540547 is actively recruiting participants. Contact the research team at liebherrh@upmc.edu for enrollment information.
Where is the NCT06540547 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT06540547 clinical trial?
NCT06540547 is sponsored by University of Pittsburgh. The principal investigator is Heather M Joseph, DO at University of Pittsburgh. The trial plans to enroll 10 participants.